These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2102483

  • 21. Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B.
    Zhirong Y, Wanqing L, Weihua P.
    Mycoses; 1999; 42(11-12):679-82. PubMed ID: 10680448
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
    Ho KM, Duff O, Chambers D, Murray R.
    Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
    Otsubo T, Maruyama K, Maesaki S, Miyazaki Y, Tanaka E, Takizawa T, Moribe K, Tomono K, Tashiro T, Kohno S.
    Antimicrob Agents Chemother; 1998 Jan; 42(1):40-4. PubMed ID: 9449258
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.
    Gavaldà J, Martín MT, López P, Gomis X, Ramírez JL, Rodríguez D, Len O, Puigfel Y, Ruíz I, Pahissa A.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3028-30. PubMed ID: 15980392
    [Abstract] [Full Text] [Related]

  • 29. [Invasive pulmonary aspergillosis in an immunocompetent patient: usefulness of thin-needle puncture-aspiration and subcutaneous reservoir with a catheter in the diagnosis and treatment].
    Fernández J, de Quirós B, Telentis M, Moreno Torrico A, Gómez Alonso C.
    Med Clin (Barc); 1989 Dec 02; 93(18):718-9. PubMed ID: 2691773
    [No Abstract] [Full Text] [Related]

  • 30. [Treatment of severe forms of aspergillosis-related pneumonia].
    Magalif NI, Ozols AIa, Balinia NA, Maslov PV, Lange AE.
    Klin Med (Mosk); 1978 Dec 02; 56(12):106-8. PubMed ID: 368427
    [No Abstract] [Full Text] [Related]

  • 31. [Pulmonary aspergillosis associated with endocarditis and cerebral embolism in a case of acute myeloblastic leukemia].
    Miyazono K, Yoshida M, Kitagawa S, Tsuboyama A, Sakamoto S, Miura Y, Shina A.
    Rinsho Ketsueki; 1984 May 02; 25(5):705-11. PubMed ID: 6381793
    [No Abstract] [Full Text] [Related]

  • 32. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
    Graybill JR, Kaster SR.
    Am Rev Respir Dis; 1984 Feb 02; 129(2):292-5. PubMed ID: 6364905
    [Abstract] [Full Text] [Related]

  • 33. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA, Owais M.
    J Antimicrob Chemother; 2006 Jul 02; 58(1):125-32. PubMed ID: 16709592
    [Abstract] [Full Text] [Related]

  • 34. Standardization of an experimental murine model of invasive pulmonary aspergillosis.
    Sheppard DC, Graybill JR, Najvar LK, Chiang LY, Doedt T, Kirkpatrick WR, Bocanegra R, Vallor AC, Patterson TF, Filler SG.
    Antimicrob Agents Chemother; 2006 Oct 02; 50(10):3501-3. PubMed ID: 17005844
    [Abstract] [Full Text] [Related]

  • 35. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA, Morrissey G, Morrissey J, Denning DW.
    J Antimicrob Chemother; 2003 Apr 02; 51(4):913-9. PubMed ID: 12654746
    [Abstract] [Full Text] [Related]

  • 36. [Severe aspergillus pneumonia (necrotizing lung aspergillosis)].
    Noll WL, van Garsse LG, Stam J.
    Ned Tijdschr Geneeskd; 1972 Apr 22; 116(17):685-90. PubMed ID: 4553265
    [No Abstract] [Full Text] [Related]

  • 37. Preclinical & pharmaceutical testing of liposomal amphotericin B.
    Gokhale PC, Kotwani RN, Dange SY, Kshirsagar NA, Pandya SK.
    Indian J Med Res; 1993 Apr 22; 98():75-8. PubMed ID: 8344735
    [Abstract] [Full Text] [Related]

  • 38. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA.
    J Infect Dis; 2003 Jul 15; 188(2):305-19. PubMed ID: 12854088
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.
    Van Etten EW, Stearne-Cullen LE, ten Kate M, Bakker-Woudenberg IA.
    Antimicrob Agents Chemother; 2000 Mar 15; 44(3):540-5. PubMed ID: 10681315
    [Abstract] [Full Text] [Related]

  • 40. Combined amphotericin B-flucytosine therapy in Aspergillus pneumonia.
    Codish SD, Tobias JS, Hannigan M.
    JAMA; 1979 Jun 01; 241(22):2418-9. PubMed ID: 374761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.